PALVELLA THERAPEUTICS, INC. 8-K

What Happened

• On June 10, 2026, Palvella Therapeutics, Inc. filed an 8-K reporting results of its 2026 Annual Meeting of Stockholders. Stockholders approved an amendment to the Palvella 2024 Equity Incentive Plan to increase authorized issuable shares by 750,000; the Plan Amendment became effective immediately upon approval. The meeting also included director elections, ratification of the independent auditor, and advisory votes on executive compensation.
• Record date for the meeting was April 13, 2026, with 14,323,686 shares outstanding and entitled to vote.

Key Details

• Equity plan amendment: Amendment No. 1 increases authorized shares under the 2024 Equity Incentive Plan by 750,000 shares; vote result — For: 7,692,709; Against: 2,475,470; Abstentions: 7,875; Broker non-votes: 1,401,415.
• Director elections (Class III, terms to 2029): George M. Jenkins (For 9,907,220; Withheld 268,834); Todd C. Davis (For 8,321,303; Withheld 1,854,751); John Doux, M.D. (For 9,958,528; Withheld 217,526). Broker non-votes reported: 1,401,415 for each director vote.
• Auditor ratified: Ernst & Young LLP reappointed as independent registered public accounting firm (For 11,557,687; Against 13,216; Abstain 6,566).
• Executive compensation votes: Say-on-pay approved (For 10,008,180; Against 160,717; Abstentions 7,157). Advisory frequency vote favored annual votes (Every Year: 9,183,170), and the Board will hold annual advisory votes going forward.

Why It Matters

• The approved 750,000-share increase gives the company additional shares to grant for employee and director equity compensation, which supports hiring and retention but can dilute existing shareholders over time. Investors should monitor future grant activity and share count changes in periodic filings.
• Board continuity was maintained with the re-election of three Class III directors, and Ernst & Young was retained as auditor—both governance items investors watch for stability and oversight. The company will continue annual say-on-pay votes per stockholder preference.